{"id":"CHEMBL103","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"RJKFOVLPORLFTN-LEKSSAKUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROGESTERONE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crinone","Cyclogest","Endometrin","Gesterol","Lutigest","Milprosa","Prochieve","Progesta-care","Progestasert","Progesterone","Progestin","Prometrium","Regumate","Serenity for women","Syngestrone","Utrogestan"],"synonyms":["NSC-64377","NSC-9704","Progesterone","Progesterone, micronized","Progesteronum","U 3672"],"crossReferences":{"DailyMed":["progesterone"],"PubChem":["144206708","144208990","144210627","17388760","17389514","26719639","26751485","26751486","50104004","50104005","50104007","56424141","75083","855688","90340816"],"Wikipedia":["Progesterone"],"drugbank":["DB00396"],"chEBI":["17026"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0007442","EFO_0003869","Orphanet_64739","EFO_0002610","EFO_0003768","EFO_1000623","EFO_0010141","HP_0000938","EFO_0004253","HP_0008209","EFO_0000400","EFO_0003893","HP_0003124","EFO_0008560","EFO_0000180","EFO_0000660","MP_0001914","MONDO_0100096","EFO_0000731","MONDO_0000831","EFO_1000237","EFO_0000668","EFO_0003922","EFO_0004320","EFO_0005204","EFO_0004248","EFO_0007453","EFO_1001465","MONDO_0007254","EFO_0003882","EFO_0002950","EFO_0007191","MONDO_0022394","MONDO_0041161","EFO_0000474","MONDO_0002050","EFO_1001375","EFO_0000712","EFO_1000645","EFO_0004701","EFO_0003917","EFO_0004215","EFO_1001491","EFO_0004319","EFO_0000545","EFO_0001645","HP_0001657","EFO_0000537","EFO_1000954","EFO_0001072","EFO_0010269","EFO_1000985","EFO_0011023","MONDO_0005147","MONDO_0011962","MONDO_0004975","EFO_0000764","MONDO_0043510"],"count":58},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 3 approved and 38 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1087630","canonicalSmiles":"CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1","inchiKey":"RAOCRURYZCVHMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anthelcide eq","Filaribits plus"],"synonyms":["NSC-758459","Oxibendazole","SK&F 30310"],"crossReferences":{"PubChem":["104171376","144204395","170465661","174007335","26747039","26747040","50100955","50104165","855911"],"drugbank":["DB04910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11266","canonicalSmiles":"O=C(Nc1nc2ccccc2[nH]1)c1cccc(CN2C(=O)N(Cc3cccc(C(=O)Nc4nc5ccccc5[nH]4)c3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"UWSVAGUSMAEUKO-QHQGJXSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL11266","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02729"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116438","canonicalSmiles":"COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O","inchiKey":"ZIUSSTSXXLLKKK-KOBPDPAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CURCUMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.i. 75300","C.i. natural yellow 3","CI-75300","Ci 75300","Curcumin","Curcumin e100","Diferuloylmethane","E 100","E-100","E100","Haldar","INS NO. 100(I)","INS-100(I)","Jianghuangsu","Kacha haldi","Kurkum","Lipocurc","Merita earth","NSC-32982","NSC-687842","Nanocurc","Natural Yellow 3","Turmeric yellow"],"crossReferences":{"PubChem":["26749327","50107568","50107570","85148703"],"Wikipedia":["Curcumin"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 45 investigational indications."}
{"id":"CHEMBL1182210","canonicalSmiles":"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1","inchiKey":"SIYLLGKDQZGJHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZETHONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzethonium","Benzethonium cation","Benzethonium ion","Benzothonium"],"crossReferences":{"PubChem":["104171294","11112266"],"drugbank":["DB11125"]},"childChemblIds":["CHEMBL221753"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1183349","canonicalSmiles":"CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1","inchiKey":"RSWOJTICKMKTER-QXLBVTBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAVUCONAZONIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAL-8557-000","BAL-8557000","BAL8557","BAL8557-000","Bal-8557","Isavuconazonium","Isavuconazonium cation","Isavuconazonium ion"],"crossReferences":{"DailyMed":["isavuconazonium%20sulfate"],"drugbank":["DB06636"],"chEBI":["85978"]},"childChemblIds":["CHEMBL3137333","CHEMBL291921","CHEMBL1688829"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for mucormycosis and aspergillosis and has 2 investigational indications."}
{"id":"CHEMBL1189432","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21","inchiKey":"JBIMVDZLSHOPLA-LSCVHKIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOPATADINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opatanol"],"synonyms":["AL-4943A","Olopatadine"],"crossReferences":{"DailyMed":["olopatadine%20hydrochloride"],"Wikipedia":["Olopatadine"],"drugbank":["DB00768"]},"childChemblIds":["CHEMBL1719"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","EFO_0007533","EFO_0007141","EFO_0005751","EFO_1001417","HP_0001742","EFO_0003956","EFO_0009450"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 4 investigational indications."}
{"id":"CHEMBL1200527","canonicalSmiles":"COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1","inchiKey":"XXZSQOVSEBAPGS-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRACURIUM BESYLATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1360","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atracurium Besilate","Atracurium besylate","Atracurium besylate preservative free","Tracrium","Tracrium preservative free"],"synonyms":["Atracurium besilate","Atracurium besylate","Atracurium dibesylate","BW 33A","BW-33A","NSC-760047"],"crossReferences":{"DailyMed":["atracurium%20besylate"],"PubChem":["144204341","174006843"],"drugbank":["DB00732"],"chEBI":["2915"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1200749","canonicalSmiles":"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"SIEYLFHKZGLBNX-NTISSMGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201193","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chirocaine","Levobupivac"],"synonyms":["Bupivacaine (-)-form hydrochloride","CHIROCAINE","Levobupivacaine hcl","Levobupivacaine hydrochloride"],"crossReferences":{"PubChem":["144205259","170465452"],"chEBI":["31772"]},"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["EFO_1002012","EFO_0003843","EFO_0000668","EFO_0002950","EFO_0003964"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 2 investigational indications."}
{"id":"CHEMBL1200775","canonicalSmiles":"CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"RGLRXNKKBLIBQS-XNHQSDQCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LEUPROLIDE ACETATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201199","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carcinil","Eligard","Eligard kit","Fensolvi kit","Leuprolide acetate","Leuprorelin","Lupron","Lupron Depot Ped","Lupron depot","Lupron depot-ped","Lupron depot-ped kit","Lutrate depot kit","Viadur"],"synonyms":["A-43818","ABBOTT-43818","Carcinil","Enantone","Fensolvi","Leuplin","Leuporelin acetate","Leuprolide acetate","Leuprolide monoacetate","Leuprorelin acetate","Lucrin","Lupaneta","Lutrate depot","Prostap","TAP-144","Tap-144-sr","Trenantone"],"crossReferences":{"DailyMed":["leuprolide%20acetate"],"PubChem":["144207056"],"chEBI":["63597"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0005204","EFO_0003869","Orphanet_64739","EFO_0001065","MONDO_0007254","EFO_1001469","HP_0031217","EFO_0002950","HP_0100543","MONDO_0000088","EFO_0000673","EFO_0000196","EFO_0000183","EFO_0000545","MONDO_0019165","EFO_0001073","MONDO_0008315","EFO_0000660","EFO_0001663","EFO_0000537","EFO_0000311","EFO_0009029","EFO_0000731","MONDO_0004975","EFO_0001378","MONDO_0024880","EFO_0003922"],"count":28},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 6 approved and 15 investigational indications."}
{"id":"CHEMBL1200975","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C","inchiKey":"SXYZQZLHAIHKKY-GSTUPEFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOCORTOLONE PIVALATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cloderm"],"synonyms":["Clocortolone 21-pivalate","Clocortolone pivalate","SH 863","SH-863"],"crossReferences":{"DailyMed":["clocortolone%20pivalate"],"PubChem":["144204183","56463639"],"chEBI":["59583"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1201043","canonicalSmiles":"CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1.[Na+]","inchiKey":"VGEOUKPOQQEQSX-OALZAMAHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHAPIRIN SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1599","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefadyl","Cephapirin sodium"],"synonyms":["BL-P 1322","BL-P-1322","Cefapirin sodium","Cephapirin sodium","Cephapirin sodium salt","NSC-179171","Sodium cefapirin"],"crossReferences":{"PubChem":["144204323","170465306","50106036","57261703"],"chEBI":["3545"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1201565","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN ALFA","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Binocrit","Epogen","Eprex","Procrit"],"synonyms":["EPO","Epoetin","Epoetin alfa","Erythropoietin","Erythropoietin for bioassays"],"crossReferences":{"DailyMed":["epoetin%20alfa-epbx"],"DrugCentral":["4995"],"Wikipedia":["Epoetin_alfa"]},"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_1000172","MONDO_0001240","MONDO_0007254","Orphanet_848","EFO_0009909","EFO_1001459","EFO_0008585","MONDO_0002280","EFO_0003100","EFO_0000712","EFO_0003884","MONDO_0005299","MONDO_0008903","EFO_0004272","EFO_0003047","HP_0012378","EFO_0003917","HP_0004936","EFO_0000198","EFO_0001416","EFO_0002618","EFO_1001779","EFO_0006859","MONDO_0008170","EFO_0001645","EFO_0000222","Orphanet_95","EFO_0001663","EFO_0000311","EFO_0003890","EFO_0000713","EFO_1001100","EFO_0009446","EFO_0000764","EFO_0000612","MONDO_0043510","EFO_0009492"],"count":37},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 4 approved and 31 investigational indications."}
{"id":"CHEMBL1201655","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nph iletin ii"],"synonyms":["Insulin susp isophane purified beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1214","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"FPPNZSSZRUTDAP-UWFZAAFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbenicillin","Geocillin","Geopen","Pyopen"],"crossReferences":{"Wikipedia":["Carbenicillin"],"drugbank":["DB00578"],"chEBI":["3393"]},"childChemblIds":["CHEMBL2105992","CHEMBL606260"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1229656","canonicalSmiles":"C[N+](C)(C)C[C@H](O)CC(=O)O","inchiKey":"PHIQHXFUZVPYII-ZCFIWIBFSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROCARNITINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02648"],"chEBI":["39547"]},"childChemblIds":["CHEMBL1876404"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231649","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@@H]2O[C@H]2C[C@@H](C)OC(=O)C[C@H]1OC(C)=O","inchiKey":"FQVHOULQCKDUCY-OGHXVOSASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOMYCIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233749","canonicalSmiles":"C#CCN1CCN(c2c(Cl)cccc2NC(=O)c2ccc(Br)o2)CC1","inchiKey":"MEFJFXHHHNDHEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233749","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08021"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233795","canonicalSmiles":"COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(O)c(O)c1","inchiKey":"TVOPERZEGKBKAY-RGVLZGJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233795","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08034"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234952","canonicalSmiles":"CCCCCCCCN[C@@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"UPZUHYMBTUUPML-KBXIAJHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Octylvalienamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Octylvalienamine"],"crossReferences":{"drugbank":["DB08321"]},"childChemblIds":["CHEMBL1922580"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235529","canonicalSmiles":"O=S1(=O)NCCCNc2nc(ncc2Br)Nc2cccc1c2","inchiKey":"AWSQADBSXFTFKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235529","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08441"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236544","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@](C)(OP(=O)(O)O)C(=O)O","inchiKey":"NLBIPGBVVPCESQ-BVDGEXFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236544","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123978","canonicalSmiles":"COc1cccc(C(N)=O)c1","inchiKey":"VKPLPDIMEREJJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Methoxy-Benzamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methoxy-Benzamide","3-Methoxybenzamide"],"crossReferences":{"PubChem":["47193707"],"drugbank":["DB03073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1240772","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C","inchiKey":"UCZDWGAJSOUHOU-VDBPWWIZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GLP-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glp-1"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1255","canonicalSmiles":"C=O","inchiKey":"WSFSSNUMVMOOMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMALDEHYDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dowling's","Veracur"],"synonyms":["E240","Formaldehyde","Formaldehyde solution","Formalin","Formalinum","Formic aldehyde","Lysoform","NSC-298885","Oxymethylene","Paraform","Superlysoform"],"crossReferences":{"PubChem":["144212755"],"Wikipedia":["Formaldehyde"],"drugbank":["DB03843"],"chEBI":["16842"]},"childChemblIds":["CHEMBL4285219"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1257070","canonicalSmiles":"Cc1oc(=O)oc1COC(=O)C1=C([C@H]2CCCO2)S[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12","inchiKey":"JQBKWZPHJOEQAO-DVPVEWDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAROPENEM MEDOXOMIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-0026","A0026","BAY-56-6854","Faropenem daloxate","Faropenem medoxomil","Fropenem daloxate","SUN-A0026"],"crossReferences":{"drugbank":["DB05659"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1263","canonicalSmiles":"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O","inchiKey":"GIIZNNXWQWCKIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SALMETEROL","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beglan","Neovent","Serevent","Soltel","Vertine"],"synonyms":["Cryogenine","GR 33343 X","GR-33343-X","GR-33343X","NSC-272693","SN408D","Salmaterol","Salmeterol","Serevent"],"crossReferences":{"DailyMed":["salmeterol%20xinafoate"],"PubChem":["144207133","26719802"],"Wikipedia":["Salmeterol"],"drugbank":["DB00938"],"chEBI":["64064"]},"childChemblIds":["CHEMBL3126379","CHEMBL1082607"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0006536","EFO_0007183","EFO_0000464","EFO_0006505","EFO_0010638","EFO_1001919","MONDO_0004979","EFO_0000341","HP_0025428","EFO_0001073"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 6 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1364551","canonicalSmiles":"Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl","inchiKey":"GNUCGROXDZMCJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINAPRINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL278819","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Neurotoxicity"],"year":1996},"tradeNames":["Cantor"],"synonyms":["30038-CB","30038CB","Minaprine dihydrochloride","Minaprine hcl","Minaprine hydrochloride","NSC-305742"],"crossReferences":{"PubChem":["144204908","170466172","26748498"],"chEBI":["51040"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1996 due to Neurotoxicity."}
{"id":"CHEMBL1364906","canonicalSmiles":"O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl","inchiKey":"PWPJGUXAGUPAHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUFENURON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGA-184699","Lufenuron","NSC-759097"],"crossReferences":{"PubChem":["144205095","144211224","170465736","26749995","26753780"],"drugbank":["DB11424"],"chEBI":["39384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL146624","canonicalSmiles":"CCc1ccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1","inchiKey":"IRNJSRAGRIZIHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOGLITAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAY-10415","J730.386F","MSD-9","MSDC-0160","Mitoglitazone","PNU-91325","U-91325"],"crossReferences":{"drugbank":["DB11721"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL146972","canonicalSmiles":"NCCOP(=O)(O)O","inchiKey":"SUHOOTKUPISOBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHORYLETHANOLAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-254167","Phosphorylcolamine","Phosphorylethanolamine"],"crossReferences":{"Wikipedia":["Phosphorylethanolamine"],"drugbank":["DB01738"],"chEBI":["17553"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1472","canonicalSmiles":"NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"XNSAINXGIQZQOO-SRVKXCTJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PROTIRELIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thypinone","Thyrel trh","Trh-cambridge"],"synonyms":["5-oxo-pro-his-pro-nh2","A-38579","ABBOTT-38579","Lopremone","NSC-760113","Protirelin","Protirelin tartrate","Protirelin, synthetic","Relefact trh","SYNTHETIC TRH","Synthetic TRH","Thyroid releasing hormone","Thyroliberin","Thyrotropin releasing hormone","Thyrotropin-releasing factor","Thyrotropin-releasing hormone"],"crossReferences":{"PubChem":["144205492","29216304"],"Wikipedia":["Thyrotropin-releasing_hormone"],"drugbank":["DB09421"],"chEBI":["35940"]},"linkedTargets":{"rows":["ENSG00000174417"],"count":1},"linkedDiseases":{"rows":["EFO_1000637","EFO_0000311"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 2 investigational indications."}
{"id":"CHEMBL147792","canonicalSmiles":"CC[C@@]1(C(=O)N[C@H](C)c2ccc(Cl)cc2)[C@@H](C)C1(Cl)Cl","inchiKey":"RXDMAYSSBPYBFW-RULNRJAQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPROPAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02946"],"chEBI":["47351"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1530428","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"AKUJBENLRBOFTD-RPRRAYFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE ACETATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decadron","Decadron-la","Dexamethasone acetate"],"synonyms":["Dectancyl","Dexamethasone 21-acetate","Dexamethasone acetate","Dexamethasone acetate anhydrous","Dexamethasone acetate monohydrate","Dexamethasoni acetas","Dexamethasoni acetas monohydrate","Fortecortin (crystal suspension)","NSC-39471"],"crossReferences":{"PubChem":["144204050","144206481","170466872","56423129","855773"],"drugbank":["DB14649"],"chEBI":["4463"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0021108","EFO_0002426","EFO_0003894","HP_0001742","HP_0002018","EFO_0000565","EFO_0003931","EFO_1001216","EFO_0000574","EFO_1000652","EFO_0001378","EFO_0009552","HP_0002013","EFO_0005752"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 5 investigational indications."}
{"id":"CHEMBL1557","canonicalSmiles":"Cl.NCCc1ccc(O)c(O)c1","inchiKey":"CTENFNNZBMHDDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOPAMINE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL59","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dopamin-Natterman","Dopamine hydrochloride","Dopmin","Dynatra","Intropin","Sabax Dopamin","Selectajet"],"synonyms":["ASL-279","Cardiosteril","Dopamine hcl","Dopamine hydrochloride","Dopamini hydrochloridum","Inotropin","NSC-169105","Tensamin"],"crossReferences":{"DailyMed":["dopamine%20hydrochloride"],"PubChem":["11532883","144208216","26747527","26747528","50106387","50106388","56424030"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","MONDO_0005180","EFO_0000373","EFO_0000612","EFO_1002048"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1607480","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.Cl","inchiKey":"UBDNTYUBJLXUNN-IFLJXUKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYTETRACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxy-kesso-tetra","Oxytetracycline hydrochloride","Terramycin"],"synonyms":["Oxytetracycline hcl","Oxytetracycline hydrochloride","Oxytetracyclini hydrochloridum"],"crossReferences":{"PubChem":["144204660","144209048","144210918","17389774","26757862"],"chEBI":["31953"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964 and has 1 investigational indication."}
{"id":"CHEMBL1619528","canonicalSmiles":"CC[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1","inchiKey":"WPUKUEMZZRVAKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPENZOLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pipenzolate","Pipenzolate cation","Pipenzolate ion"],"crossReferences":{"Wikipedia":["Pipenzolate"],"drugbank":["DB13844"]},"childChemblIds":["CHEMBL1401367"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL167150","canonicalSmiles":"COP(=O)(OC)C(O)C(Cl)(Cl)Cl","inchiKey":"NFACJZMKEDPNKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLORFON","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bilarcil"],"synonyms":["BAY-A 9826","BAYER L 1359","BAYER-L-1359","DETF","ENT-19,763","Metrifonate","Metrifonatum","Metriphonate","NSC-8923","Trichlorfon","Trichlorofon","Triclorfon","WEC-50"],"crossReferences":{"PubChem":["104171375","144204394","144208805","144211177","170465707","26752327","855564"],"drugbank":["DB11473"],"chEBI":["6908"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for helminthiasis."}
{"id":"CHEMBL1697762","canonicalSmiles":"O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1","inchiKey":"KUEUWHJGRZKESU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICERITROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Niceritrol","Pentaerithritol tetranicotinate","Perycit"],"crossReferences":{"PubChem":["170465789"],"drugbank":["DB13441"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL171148","canonicalSmiles":"O=C1N(Cc2ccccc2)[C@H](COc2ccccc2)[C@H](O)[C@@H](O)[C@@H](COc2ccccc2)N1Cc1ccccc1","inchiKey":"SQBOSZXDOHQFAA-ZRTHHSRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL171148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01732"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1795072","drugType":"Protein","blackBoxWarning":true,"name":"ZICONOTIDE ACETATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prialt"],"synonyms":["Ziconotide acetate"],"crossReferences":{"DailyMed":["ziconotide%20acetate"]},"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["HP_0001945","EFO_0003843"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for pain and fever. This drug has a black box warning from the FDA."}
{"id":"CHEMBL18116","canonicalSmiles":"Cc1cccc(N2CC(CO)OC2=O)c1","inchiKey":"MXUNKHLAEDCYJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLOXATONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Humoryl","Toloxatone"],"crossReferences":{"Wikipedia":["Toloxatone"],"drugbank":["DB09245"]},"linkedTargets":{"rows":["ENSG00000189221"],"count":1},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1852164","canonicalSmiles":"C/C(=N\\O)c1nc([C@@H](O)[C@H](O)[C@H](O)CO)c[nH]1","inchiKey":"AMXVYJYMZLDINS-RSWLNLDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LX-2931","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LX 2931","LX-3305","LX2931","LX3305","Lx-2931","Lx3305"],"crossReferences":{"drugbank":["DB06297"]},"childChemblIds":["CHEMBL1802099"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL186","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1","inchiKey":"HVFLCNVBZFFHBT-ZKDACBOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFEPIME","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxipime","Renapime"],"synonyms":["BMY-28142","Cefepime","J01DE01","VNRX-5022"],"crossReferences":{"DailyMed":["cefepime%20hydrochloride"],"Wikipedia":["Cefepime"],"drugbank":["DB01413"],"chEBI":["478164"]},"childChemblIds":["CHEMBL1201736","CHEMBL1200962"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 10 investigational indications."}
{"id":"CHEMBL1908919","canonicalSmiles":"CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)nc2)cc1","inchiKey":"YNDIAUKFXKEXSV-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBETAPIR","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Av-45","Florbetapir"],"crossReferences":{"DailyMed":["florbetapir%20f-18"]},"childChemblIds":["CHEMBL1774461"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for alzheimer disease and cognitive impairment."}
{"id":"CHEMBL2089125","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)c1nc2ccccc2s1","inchiKey":"MAJHCCQPIDXPAN-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2089125","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08624"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096629","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUSSIAN BLUE INSOLUBLE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antidotum-thallii-heyl","Radiogardase (prussian blue)","Radiogardase-cs"],"synonyms":["Ferric Hexacyanoferrate(II)","Ferric ferrocyanide","Ferric hexacyanoferrate","Ferric hexacyanoferrate(ii)","Ferrum cyanatum","Insoluble prussian blue","Iron(iii) ferrocyanide","NSC-8665","Prussian Blue","Prussian blue","Prussian blue insoluble","Radiogardase"],"crossReferences":{"DrugCentral":["4860"],"Wikipedia":["Prussian_blue"],"chEBI":["30069"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003."}
{"id":"CHEMBL2104264","canonicalSmiles":"CCN(CC)CCn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"AWKLBIOQCIORSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAMIPHYLLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dietamiphylline","Etamiphyllin","Etamiphylline","NSC-38348"],"crossReferences":{"drugbank":["DB13592"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104619","canonicalSmiles":"Cc1nc2c(C)cccn2c(=O)c1CCN1CCC(c2noc3cc(F)ccc23)CC1","inchiKey":"ZZQNEJILGNNOEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCAPERIDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ocaperidone","R 79598","R-79598"],"crossReferences":{"drugbank":["DB06229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104895","canonicalSmiles":"CN1CCC2=C(C1)c1ccccc1Cc1ccccc12","inchiKey":"GVPIXRLYKVFFMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SETIPTILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORG 8282","Setiptiline","Setiptiline maleate"],"crossReferences":{"drugbank":["DB09304"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105717","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC","inchiKey":"ONIQOQHATWINJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CABOZANTINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","BMS-907351 FREE BASE","Cabozantinib","XL-184","XL-184 FREE BASE","XL184"],"crossReferences":{"DailyMed":["cabozantinib%20s-malate"],"PubChem":["137276008"],"drugbank":["DB08875"],"chEBI":["72317"]},"childChemblIds":["CHEMBL2103868"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000637","EFO_0001075","EFO_1000592","MONDO_0003890","EFO_0000756","EFO_0000681","EFO_1000657","EFO_1001951","MONDO_0002974","EFO_0000389","EFO_0000182","EFO_1000251","EFO_0008528","EFO_0000501","EFO_0000641","MONDO_0015277","MONDO_0018352","EFO_1001949","EFO_0002618","MONDO_0002108","EFO_0000349","EFO_1001512","MONDO_0004669","EFO_1001968","MONDO_0004986","MONDO_0008315","EFO_1000489","EFO_0000335","EFO_0008524","EFO_1000613","EFO_0001378","EFO_1000796","EFO_0000563","EFO_0003016","EFO_1001901","MONDO_0015686","EFO_1001465","MONDO_0007254","MONDO_0024879","EFO_0000305","EFO_0000272","MONDO_0001187","EFO_1000044","EFO_0003968","EFO_1001974","EFO_0000673","EFO_0000326","EFO_0002499","EFO_0000707","EFO_0000239","EFO_0002617","EFO_0002914","EFO_0000616","EFO_0005220","EFO_1000616","EFO_1000603","Orphanet_44890","EFO_0000222","EFO_0000313","EFO_0004243","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0000640","EFO_0003863","MONDO_0002120","EFO_0002892","EFO_0001421","MONDO_0002367","EFO_0000519"],"count":70},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 8 approved and 52 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105731","canonicalSmiles":"Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O.Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O.O.O=S(=O)(O)O","inchiKey":"NOJBHZIZNPMQRT-CBASKZFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCALERET SULFATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1672973","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Encaleret sulfate","Jit-305","MK-5442","MK5442","Mk-5442"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106530","canonicalSmiles":"O=C(N/N=C/C=C/c1ccc([N+](=O)[O-])o1)c1ccc([N+](=O)[O-])s1","inchiKey":"IDUMOVRJNBNOTR-BIZLIJPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nifurzide","Ricridene"],"crossReferences":{"drugbank":["DB13325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108672","drugType":"Antibody","blackBoxWarning":false,"name":"VORSETUZUMAB MAFODOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sgn-75"],"synonyms":["SGN-75","Vorsetuzumab mafodotin"],"linkedTargets":{"rows":["ENSG00000125726"],"count":1},"linkedDiseases":{"rows":["EFO_0000681"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108713","drugType":"Antibody","blackBoxWarning":false,"name":"IODINE I 124 GIRENTUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Redectane"],"synonyms":["124ICG250","Girentuximab i-124","Girentuximab iodine-124","Iodine (124i) girentuximab","Iodine i 124 girentuximab","cG250 (124I)"],"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","MONDO_0002367"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108792","drugType":"Protein","blackBoxWarning":false,"name":"TIFACOGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Extrinsic pathway inhibitor","LAC-I","LACI","SC-59735","Tifacogin","Tissue factor pathway inhibitor"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108800","drugType":"Antibody","blackBoxWarning":false,"name":"INDIUM IN 111 CAPROMAB PENDETIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prostascint"],"synonyms":["(sup 111)in-capromab pendetide","7E11-C5.3","CYT-351","Capromab pendetide","Indium (111in) capromab pendetide","Indium in 111 capromab pendetide","Indium in-111 capromab pendetide"],"description":"Antibody drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109355","drugType":"Antibody","blackBoxWarning":false,"name":"DUSIGITUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dusigitumab","MEDI-573","MEDI573"],"linkedTargets":{"rows":["ENSG00000167244","ENSG00000017427"],"count":2},"linkedDiseases":{"rows":["EFO_0000182","MONDO_0007254","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109447","drugType":"Antibody","blackBoxWarning":false,"name":"LYM-1","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Oncolym"],"synonyms":["LYM-1","Lym-1"],"linkedTargets":{"rows":["ENSG00000196126"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109514","drugType":"Antibody","blackBoxWarning":false,"name":"PTI-6D2","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PTI-6D2"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109613","drugType":"Antibody","blackBoxWarning":false,"name":"PF-04236921","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 4236921","PF-04236921","PF-4236921","Pf-04236921"],"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0002690","EFO_0000384"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109622","drugType":"Antibody","blackBoxWarning":false,"name":"PF-04605412","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04605412","Pf-04605412"],"linkedTargets":{"rows":["ENSG00000161638"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110368","canonicalSmiles":"C/N=C(\\NC)NCc1ccccc1.C/N=C(\\NC)NCc1ccccc1.O=S(=O)(O)O","inchiKey":"YTIJUXVIZLYQTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANIDINE SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201260","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bendogen","Esbatal","Tenathan"],"synonyms":["BW-467-C-60","Betanidine sulfate","Betanidine sulphate","Bethanidine sulfate","Bethanidine sulphate","NSC-106563"],"crossReferences":{"chEBI":["31279"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2110732","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1","inchiKey":"LVXJQMNHJWSHET-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DACOMITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dacomitinib","Pf-00299804"],"crossReferences":{"DailyMed":["dacomitinib"],"drugbank":["DB11963"]},"childChemblIds":["CHEMBL2105719"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000313","EFO_0003060","EFO_1001951","EFO_0000311","EFO_0009708","EFO_0005570","MONDO_0008903","EFO_0001421","MONDO_0001657","EFO_0004284","EFO_1001094","EFO_0003833","EFO_0000707","EFO_0000519","EFO_0000181"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 14 investigational indications."}
{"id":"CHEMBL2110788","canonicalSmiles":"CC[N+]1(CC)CCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1","inchiKey":"ZKCWITXZGWUJAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZILONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzilone","Benzilonium cation","Benzilonium ion"],"crossReferences":{"drugbank":["DB13369"]},"childChemblIds":["CHEMBL2106061"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110791","canonicalSmiles":"CCN(CC)CCCNCc1cc(Cl)c2cccnc2c1O","inchiKey":"HOFHLRCDGWSLHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAMOXYQUIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clamoxyquine"],"childChemblIds":["CHEMBL2106065"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2151572","canonicalSmiles":"O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1","inchiKey":"SSRDSYXGYPJKRR-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCENICLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EVP-6124","Encenicline","Evp-6124","MT-4666","MT4666"],"crossReferences":{"drugbank":["DB11726"]},"childChemblIds":["CHEMBL3137323"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0005090","EFO_0009386","HP_0000726","EFO_0001421","MONDO_0004975","EFO_0005411"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2219418","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5","inchiKey":"XNKCCCKFOQNXKV-ZRSCBOBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXEGOL","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moventig"],"synonyms":["AZ-13337019","NKTR-118","Naloxegol"],"crossReferences":{"DailyMed":["naloxegol%20oxalate"],"drugbank":["DB09049"],"chEBI":["82975"]},"childChemblIds":["CHEMBL2219416"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0004567","EFO_0005611","MONDO_0043510","EFO_0003843","EFO_0003060","HP_0002019","MONDO_0002203"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL225983","canonicalSmiles":"O=C(O)[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"FEWJPZIEWOKRBE-XIXRPRMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(2S,3R)-2,3-Dihydroxysuccinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S,3R)-2,3-Dihydroxysuccinic Acid","Meso-Tartrate"],"crossReferences":{"drugbank":["DB14756"],"chEBI":["15673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23254","canonicalSmiles":"CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1","inchiKey":"ZKDXRFMOHZVXSG-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PURVALANOL B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11114141"],"drugbank":["DB02733"],"chEBI":["49840"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL240163","canonicalSmiles":"C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"XAGMUUZPGZWTRP-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAZUFLOXACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pazufloxacin","T-3761"],"crossReferences":{"PubChem":["144206084","170465985","26719888","49681761","50112787"],"drugbank":["DB11774"]},"childChemblIds":["CHEMBL3764913"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_1000829","EFO_0000771","EFO_0004992"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL249530","canonicalSmiles":"Brc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12","inchiKey":"SMIZFGZXFDGISG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL249530","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08535"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL265325","canonicalSmiles":"NC1(C(=O)O)CC1","inchiKey":"PAJPWUMXBYXFCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1-Aminocyclopropane carboxylic acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Amino-Cyclopropanecarboxylic Acid","1-Aminocyclopropane Carboxylic Acid","1-Aminocyclopropanecarboxylic Acid"],"crossReferences":{"PubChem":["11110708","26749953","26756617","90340879"],"Wikipedia":["1-Aminocyclopropane-1-carboxylic_acid"],"drugbank":["DB02085"],"chEBI":["18053"]},"childChemblIds":["CHEMBL1255660"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296419","canonicalSmiles":"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1","inchiKey":"GXDALQBWZGODGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTEMIZOLE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," Malasia"],"classes":["Cardiotoxicity"],"year":1999},"tradeNames":["Hismanal","Pollon-eze"],"synonyms":["Astemizole","GNF-Pf-2461","NSC-329963","NSC-759570","R 43,512"],"crossReferences":{"PubChem":["104171329","11112828","124882660","124882662","144204231","144207293","170465888","26746979","26751496","26751497","56422418","855746"],"Wikipedia":["Astemizole"],"drugbank":["DB00637"],"chEBI":["2896"]},"childChemblIds":["CHEMBL1788122"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for allergic disease. It was withdrawn in United States and  Malasia initially in 1999 due to Cardiotoxicity."}
{"id":"CHEMBL304087","canonicalSmiles":"COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1","inchiKey":"JBPUGFODGPKTDW-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERIMEPODIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Merimepodib","VI-21,497","VI-21497","VX-497"],"crossReferences":{"drugbank":["DB04862"]},"linkedTargets":{"rows":["ENSG00000106348"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL305906","canonicalSmiles":"CCCCCCCCCCCCCCCC[n+]1ccccc1","inchiKey":"NEUSVAOJNUQRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYLPYRIDINIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cetylpyridinium"],"crossReferences":{"PubChem":["124890337"],"drugbank":["DB11073"],"chEBI":["32914"]},"childChemblIds":["CHEMBL2003538","CHEMBL34833","CHEMBL1710321","CHEMBL334255"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3087515","canonicalSmiles":"COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1","inchiKey":"ZFPZEYHRWGMJCV-ZHALLVOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVOGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFQ-056","AFQ056","Mavoglurant"],"crossReferences":{"drugbank":["DB13004"]},"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0003086","Orphanet_399","EFO_0002610","EFO_0004329","MONDO_0005180","EFO_0001421","MONDO_0007079","EFO_0010445","EFO_0004242","EFO_0004152","Orphanet_908"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL3137348","drugType":"Enzyme","blackBoxWarning":false,"name":"SENREBOTASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-214868","SXN-100323","Senrebotase"],"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137352","drugType":"Antibody","blackBoxWarning":false,"name":"RALPANCIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05335810","RN-317","RN317","Ralpancizumab"],"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["HP_0003124"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL314854","canonicalSmiles":"CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1","inchiKey":"KKGQTZUTZRNORY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINGOLIMOD","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilenya"],"synonyms":["FTY-720","Fingolimod"],"crossReferences":{"DailyMed":["fingolimod%20hydrochloride"],"Wikipedia":["Fingolimod"],"drugbank":["DB08868"],"chEBI":["63115"]},"childChemblIds":["CHEMBL544665","CHEMBL3526818"],"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["MONDO_0005090","EFO_1000868","EFO_0007405","EFO_0003929","EFO_0000540","Orphanet_778","EFO_0000305","HP_0000083","HP_0100543","EFO_0003840","EFO_1001231","MONDO_0100096","EFO_0008520","MONDO_0005301","EFO_0000712","MONDO_0004979","EFO_0002499","MONDO_0004976","EFO_0000519"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for multiple sclerosis and immune system disease and has 18 investigational indications."}
{"id":"CHEMBL3304485","canonicalSmiles":"CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1","inchiKey":"DNHPDWGIXIMXSA-CXNSMIOJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENAPANOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AZD-1722","Tenapanor"],"crossReferences":{"DailyMed":["tenapanor%20hydrochloride"],"drugbank":["DB11761"]},"childChemblIds":["CHEMBL3301627"],"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0003884","HP_0002905","HP_0002019","MONDO_0002203"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3341965","canonicalSmiles":"FC(F)(F)c1ccc2c(c1)[C@H]1CNC[C@@H]2C1","inchiKey":"RNOBTWYQAWEZHH-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3341965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL35306","canonicalSmiles":"C[C@@H]([C@H](N)C(=O)N[C@H](C(=O)O)[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)[C@H](O)c1ccc(O)cn1","inchiKey":"WWJFFVUVFNBJTN-VHDFTHOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIKKOMYCIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nikkomycin","Nikkomycin Z"],"crossReferences":{"drugbank":["DB12939"],"chEBI":["623918"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545262","drugType":"Antibody","blackBoxWarning":false,"name":"SACITUZUMAB GOVITECAN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trodelvy"],"synonyms":["HRS7-SN38","HRS7-SN38-ANTIBODY-DRUG-CONJUGATE","IMMU-132","Sacituzumab govitecan","Sacituzumab govitecan-hziy"],"crossReferences":{"DailyMed":["sacituzumab%20govitecan-hziy"]},"linkedTargets":{"rows":["ENSG00000198900","ENSG00000184292"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003863","EFO_0005537","MONDO_0007254","EFO_0008528","EFO_0000702","EFO_1001512","EFO_0000305","EFO_0003060","EFO_0000519","MONDO_0008315","MONDO_0001187","EFO_0000311"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL356752","canonicalSmiles":"Cc1c(CC(N)=O)c2cc(OCCCC(=O)O)ccc2n1Cc1ccccc1","inchiKey":"STENXUCYNKOBHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356752","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3597971","canonicalSmiles":"Cc1cc(C)nc(N2CC3CN(C(=O)c4c(F)cccc4-n4nccn4)CC3C2)n1","inchiKey":"SQOCEMCKYDVLMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELTOREXANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-42847922","MIN-202","Seltorexant"],"childChemblIds":["CHEMBL4780973"],"linkedTargets":{"rows":["ENSG00000137252"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0002009","EFO_0001421","EFO_0003918","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3707205","canonicalSmiles":"CC[N+](C)(CC)CCOC(c1ccccc1)c1ccccc1","inchiKey":"IHFMXHPNVAVTCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(2-BENZHYDRYLOXYETHYL)DIETHYL-METHYLAMMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3707204"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707216","canonicalSmiles":"CN(C)c1ccc(O)cc1","inchiKey":"JVVRCYWZTJLJSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-DIMETHYLAMINOPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-dimethylaminophenol"],"crossReferences":{"drugbank":["DB13549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707304","canonicalSmiles":"CO[C@@H]1[C@H](C(=O)O)O[C@@H](O[C@@H]2[C@@H](NC(C)=O)[C@H](OC)O[C@H](CO)[C@@H]2OS(=O)(=O)O)[C@H](O)[C@H]1O","inchiKey":"FPJHWYCPAOPVIV-VOZMEZHOSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DERMATAN SULFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dermatan sulfate","Dermatan sulphate"],"crossReferences":{"DrugCentral":["2973"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL380500","canonicalSmiles":"Nc1nccc(-c2c3c(O)ccnc3n3c(N)nccc23)n1","inchiKey":"RTHKPHCVZVYDFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARIOLIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Variolin B"],"crossReferences":{"drugbank":["DB08694"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833354","canonicalSmiles":"NC(=S)NS(=O)(=O)c1ccc(N)cc1.NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"ZLYHTQKHXIVMLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFATOLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfatolamide","Sulphatolamide"],"crossReferences":{"DrugCentral":["4724"],"drugbank":["DB13547"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL38380","canonicalSmiles":"O=S(=O)(c1cccc2cnccc12)N1CCCNCC1","inchiKey":"NGOGFTYYXHNFQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASUDIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT 877","AT-877","Fasudil","HA 1077","HA-1077","NSC-759827","ZK-258594"],"crossReferences":{"PubChem":["103905389","103905390","104171358","11113364","124883255","124883258","124883259","26751605","92708292"],"Wikipedia":["Fasudil"],"drugbank":["DB08162"]},"childChemblIds":["CHEMBL4459126","CHEMBL541388","CHEMBL4435188"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["HP_0000726","EFO_1001157","EFO_0000319","EFO_0000612","MONDO_0004976","EFO_1001158","EFO_0002615"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3989987","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PATISIRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ALN-18328","ALN-TTR02","Genz-438027","Patisiran","SAR-438037"],"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_1001875","Orphanet_271861","Orphanet_85447"],"count":4},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL404630","canonicalSmiles":"Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl","inchiKey":"JLIRVZVVCCIAKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404630","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07601"],"chEBI":["90529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL410834","canonicalSmiles":"COc1cc2ncnc(N3CC[C@@H](Oc4ccc5ccccc5c4)C3)c2cc1OC","inchiKey":"UPTQSRGSSJRBKJ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL410834","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425148","canonicalSmiles":"COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O","inchiKey":"MATGKVZWFZHCLI-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MATAIRESINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Matairesinol","Matairesinol"],"crossReferences":{"Wikipedia":["Matairesinol"],"drugbank":["DB04200"],"chEBI":["6698"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297065","canonicalSmiles":"CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)C2CC(=O)O1.CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@H]3[C@@H]4C[C@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@H]4C(C)=C[C@H]3[C@@H]2CC(=O)O1","inchiKey":"JFLRKDZMHNBDQS-UCQUSYKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPINOSAD","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Natroba"],"synonyms":["Blackhawk","Comfortis","DE-105","Extinosad","LY-232105","Natrova","Naturalyte","PP-105","Spinosad","Spinosad (ema epar: veterinary)","Spinosyns spinosad","Spintor","XDE-105"],"crossReferences":{"DailyMed":["spinosad"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for lice infestation."}
{"id":"CHEMBL4297444","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOMOLIBDATE ION","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Molybdenum sulfide (mos42-)","Tetrathiomolybdate","Tetrathiomolybdate (mos42-)","Tetrathiomolybdate 2-ion","Tetrathiomolybdate ion","Tetrathiomolybdate(2-)","Thiomolybdate (mos42-)","Tiomolibdate ion"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL4297484","canonicalSmiles":"COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(C#N)c3)CC2)CC1","inchiKey":"PLMAPPWZOQMTBI-XUTJKUGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BP-14979","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BP-14979","Bp-14979","Bp1.4979"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297488","canonicalSmiles":"CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12","inchiKey":"YCVGLKWJKIKVBI-MJGOQNOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-7001","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-7001","CT7001","Ct-7001","Ct7001","ICEC-0942","ICEC0942","Samuraciclib"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297518","canonicalSmiles":"CCCOc1ccc(S(=O)(=O)N2CCN(CCO)CC2)cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1","inchiKey":"MIJFNYMSCFYZNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRODENAFIL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mirodenafil","SK-3530 FREE BASE","SK3530 FREE BASE"],"crossReferences":{"drugbank":["DB11792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297905","drugType":"Antibody","blackBoxWarning":false,"name":"OSOCIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 1213790","BAY-1213790","Bay1213790","Osocimab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4300944","canonicalSmiles":"CCCCCc1ccc(-c2cc3cn([C@H]4C[C@H](O)[C@@H](COC(=O)[C@@H](N)C(C)C)O4)c(=O)nc3o2)cc1","inchiKey":"FJRRWJMFUNGZBJ-RBVMOCNTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALNIVUDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valnivudine"],"childChemblIds":["CHEMBL4297380"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL438139","canonicalSmiles":"COc1ccc([C@@]23Oc4cc(OC)cc(OC)c4[C@]2(O)[C@H](O)[C@H](C(=O)N(C)C)[C@H]3c2ccccc2)cc1","inchiKey":"DAPAQENNNINUPW-IDAMAFBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCAGLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rocaglamide"],"crossReferences":{"PubChem":["458129","92763845"],"drugbank":["DB15495"],"chEBI":["66309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL446143","canonicalSmiles":"NCCC[C@H](N)C(=O)O","inchiKey":"AHLPHDHHMVZTML-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORNITHINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-758894","Ornithine","Ornithine, (l)-isomer"],"crossReferences":{"Wikipedia":["Ornithine"],"drugbank":["DB00129"],"chEBI":["15729"]},"childChemblIds":["CHEMBL3138616","CHEMBL3184113","CHEMBL4297204"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4594230","drugType":"Protein","blackBoxWarning":false,"name":"LIPEGFILGRASTIM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lonquex"],"synonyms":["Lipegfilgrastim","XM-22","XM22"],"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0000174","EFO_0000574"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594287","canonicalSmiles":"COc1cc2c(cc1OC)-c1c/c(=N\\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2","inchiKey":"CSOBIBXVIYAXFM-BYNJWEBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENSIFENTRINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensifentrine","Ls-193,855","Ls-193855","RPL-554","RPL554"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594463","drugType":"Antibody","blackBoxWarning":false,"name":"AVDORALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-c5ar-215","Avdoralimab","IPH-5401","Iph5401","NN-8210","NNC-0215-0384"],"linkedTargets":{"rows":["ENSG00000197405"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100096","EFO_0007187"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594499","drugType":"Unknown","blackBoxWarning":false,"name":"SIG12D LODER","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Panc1 (krasgat)","Sig12d loder"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650422","drugType":"Unknown","blackBoxWarning":false,"name":"ROSE-010","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ROSE-010","Rose-010"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650470","drugType":"Protein","blackBoxWarning":false,"name":"EFPEGLENATIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efpeglenatide","HM-11260C","HM11260C","Hm11260c","Langlenatide","SAR-439977","SAR439977"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0001073","EFO_0000400","MONDO_0005148"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650525","drugType":"Unknown","blackBoxWarning":false,"name":"VRC-01","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VRC-01","VRC01","Vrc-01","Vrc01"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL469","canonicalSmiles":"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O","inchiKey":"OZWKMVRBQXNZKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOROLAC","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ketorolac"],"crossReferences":{"DailyMed":["ketorolac%20tromethamine"],"PubChem":["174007295","90341692"],"Wikipedia":["Ketorolac"],"drugbank":["DB00465"],"chEBI":["76223"]},"childChemblIds":["CHEMBL1201124"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","EFO_0004683","EFO_1001139","EFO_1001178","EFO_0008571","EFO_0003931","HP_0100790","EFO_0004253","EFO_1000652","EFO_0004616","HP_0003419","EFO_0009620","EFO_1001250","EFO_0005854","HP_0012532","EFO_1000906","MONDO_0008170","HP_0000616","MONDO_0100431","EFO_0000546","HP_0002027","MP_0001845","EFO_1000859","EFO_0000516","HP_0000540","MONDO_0002258","EFO_0000668","EFO_1001158","EFO_1001434","MONDO_0018373","MONDO_0003005","EFO_0000278","HP_0000545","EFO_0008507","MONDO_0007254","MONDO_0002087","MONDO_0005277","MONDO_0002158","EFO_0009444","EFO_0003959","MONDO_0005129","HP_0002015","EFO_0005752","EFO_0004210","HP_0200026","EFO_0000545","HP_0011110","EFO_0003770","HP_0003418","EFO_0003843","HP_0002315","EFO_0005755","EFO_1001412","HP_0030839","EFO_0010680","EFO_0000649","EFO_0004273","EFO_0005611","EFO_0003918","MONDO_0005178","MONDO_0005475"],"count":62},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 6 approved and 35 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL479789","canonicalSmiles":"N[C@@H](Cc1ccc(O)c(I)c1)C(=O)O","inchiKey":"UQTZMGFTRHFAAM-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOTYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50104021","855708","90341583"],"Wikipedia":["3-Iodotyrosine"],"drugbank":["DB01758"],"chEBI":["27847"]},"childChemblIds":["CHEMBL2107690"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802208","drugType":"Protein","blackBoxWarning":false,"name":"PEGIPANERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Livnate","Quellor","Xpro"],"synonyms":["DN-TNF","INB-03","INB03","Inb03","Pegipanermin","XENP-1595","XENP1595","XPRO-1595","XPro1595","Xpro1595"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL480626","canonicalSmiles":"CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O","inchiKey":"JZODKRWQWUWGCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Di-Tert-Butylhydroquinone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Di-Tert-Butylhydroquinone"],"crossReferences":{"PubChem":["11113984","144210703","26752127","47193730"],"drugbank":["DB04638"],"chEBI":["41094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL486226","canonicalSmiles":"Cn1c(N2CCCCS2(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O","inchiKey":"VNIWZCGZPBJWBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-707035","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms 707035","Bms-707035"],"childChemblIds":["CHEMBL486035"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL501","canonicalSmiles":"CC(N)Cc1ccccc1.O=S(=O)(O)O","inchiKey":"SOFQDLYSFOWTJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMPHETAMINE SULFATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amphetamine sulfate","Benzadrine","Evekeo","Evekeo odt"],"synonyms":["Amfetamine sulfate","Amfetamine sulphate","Amphetamine Sulfate","Amphetamine sulfate","Astedin","Benzedrine","Dl-amphetamine sulfate","Dl-amphetamine sulphate","NSC-170999"],"crossReferences":{"DailyMed":["amphetamine%20sulfate"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002610","MONDO_0016158"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for attention deficit hyperactivity disorder and narcolepsy-cataplexy syndrome and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL505","canonicalSmiles":"CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1","inchiKey":"SOYKEARSMXGVTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENIRAMINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antagonate","Chlor-Trimeton","Chlorphenamine","Chlorpheniramine","Isoclor","Kloromin","Phenetron","Teldrin"],"crossReferences":{"DailyMed":["chlorpheniramine%20maleate"],"PubChem":["174006626","174007153","50110994","90340572"],"TG-GATEs":["90"],"Wikipedia":["Chlorphenamine"],"drugbank":["DB01114"],"chEBI":["52010"]},"childChemblIds":["CHEMBL1201659","CHEMBL180454","CHEMBL1659"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007486","HP_0012735","EFO_0003958","MONDO_0005271","MONDO_0004979","EFO_0007328","EFO_0003956","EFO_0004239"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL506649","canonicalSmiles":"CCCC[C@H](CN(O)C=O)C(=O)N1CCC[C@H]1c1nc2ccccc2o1","inchiKey":"QDDZLTVSNABZIK-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL506649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508112","canonicalSmiles":"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1","inchiKey":"AFZSMODLJJCVPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOTHIAZYL DISULFIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-87F4"],"crossReferences":{"PubChem":["144204657","170465723","17390019","26752944"],"drugbank":["DB14201"],"chEBI":["53239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL509485","canonicalSmiles":"CNS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N[C@@H]3CCC[C@H]3N(C)C)n2)cc1","inchiKey":"CAUFYHKGKDJMQG-HZPDHXFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509485","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08341"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL570537","canonicalSmiles":"CC(C)(C)Nc1nc(N)c(C(=O)c2ccccc2)s1","inchiKey":"KEHNGAHNKVLUSC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL570537","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08778"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL583","canonicalSmiles":"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1","inchiKey":"AIJTTZAVMXIJGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GREPAFLOXACIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Germany"],"classes":["Cardiotoxicity"],"year":1999},"tradeNames":[],"synonyms":["Grepafloxacin","Raxar"],"crossReferences":{"PubChem":["50112780"],"Wikipedia":["Grepafloxacin"],"drugbank":["DB00365"],"chEBI":["5543"]},"childChemblIds":["CHEMBL1200393"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for bacterial disease and has 1 investigational indication. It was withdrawn in United States,  United Kingdom,  United States and  Germany initially in 1999 due to Cardiotoxicity."}
{"id":"CHEMBL592445","canonicalSmiles":"CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1","inchiKey":"DWZAEMINVBZMHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEDATOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gedatolisib","PF-05212384","PKI-587"],"crossReferences":{"drugbank":["DB11896"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001480","EFO_0005537","MONDO_0007254","EFO_0000222","EFO_0004230","EFO_0003060","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL593","canonicalSmiles":"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1","inchiKey":"WHBIGIKBNXZKFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELAVIRDINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Delavirdine","U-90152"],"crossReferences":{"PubChem":["144206190","170464664"],"Wikipedia":["Delavirdine"],"drugbank":["DB00705"],"chEBI":["119573"]},"childChemblIds":["CHEMBL929"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for viral disease and has 2 investigational indications."}
{"id":"CHEMBL61479","canonicalSmiles":"Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1","inchiKey":"XWAONOGAGZNUSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIRAMESINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Siramesine"],"crossReferences":{"drugbank":["DB06555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62382","canonicalSmiles":"C[Se]C[C@H](N)C(=O)O","inchiKey":"XDSSPSLGNGIIHP-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLSELENOCYSTEINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylselenocysteine","Se-Methylselenocysteine"],"crossReferences":{"PubChem":["90341483"],"drugbank":["DB12697"],"chEBI":["27812"]},"childChemblIds":["CHEMBL1256174"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL63857","canonicalSmiles":"O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21","inchiKey":"KJFMBFZCATUALV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOLPHTHALEIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alophen","Ex-lax","Prulet"],"synonyms":["Phenolphthalein"],"crossReferences":{"PubChem":["104171370","124883460","144204389","144209417","144210602","170465559","17389766","26747045","26747046","26751565","50100917","50104178","56422367","855935"],"Wikipedia":["Phenolphthalein"],"drugbank":["DB04824"],"chEBI":["34914"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for constipation."}
{"id":"CHEMBL68828","canonicalSmiles":"C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1)C(=O)CF","inchiKey":"RYABQRLJLIHDIP-KSSFIOAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL68828","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08775"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL74078","canonicalSmiles":"O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1","inchiKey":"QTNUWEKKZHSUQO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL74078","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08299"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL761","canonicalSmiles":"c1ccc2c(CC3=NCCN3)cccc2c1","inchiKey":"CNIIGCLFLJGOGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHAZOLINE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nafazair","Nafazolin","Naphazoline"],"crossReferences":{"DailyMed":["naphazoline%20hydrochloride"],"PubChem":["11112411","26751615"],"Wikipedia":["Naphazoline"],"drugbank":["DB06711"]},"childChemblIds":["CHEMBL1706"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0000616","MP_0001845","EFO_0007486","EFO_0000678","EFO_0007328","EFO_0005751","EFO_0007141","HP_0001742","EFO_0007214","EFO_0003956"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 5 approved and 6 investigational indications."}
{"id":"CHEMBL878","canonicalSmiles":"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C","inchiKey":"AQCHWTWZEMGIFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOLAZONE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diulo","Metenix","Metolazone","Mykrox","Xuret","Zaroxolyn"],"synonyms":["Metazoline","Metolazone","Metozalone","NSC-759581","Normelan","Oldren","SR 720-22","SR-720-22"],"crossReferences":{"DailyMed":["metolazone"],"PubChem":["144203737","144207075","170464665","26747536","26747537","26753589","26753590","56463247"],"Wikipedia":["Metolazone"],"drugbank":["DB00524"],"chEBI":["64354"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["HP_0012664","EFO_0003144","EFO_0003884","EFO_0000373","EFO_0000319","EFO_0000668","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL969","canonicalSmiles":"O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1","inchiKey":"MWQCHHACWWAQLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZEPAM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Centrax","Demetrin","Prazepam"],"synonyms":["NSC-277179","Prazepam","Prazepam civ","W 4020","W-4020"],"crossReferences":{"PubChem":["144206168","144207274","50113069"],"Wikipedia":["Prazepam"],"drugbank":["DB01588"],"chEBI":["8362"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0005230"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for anxiety."}
